Literature DB >> 18648713

Novel topical drug delivery systems and their potential use in acne vulgaris.

M Taglietti1, C N Hawkins, J Rao.   

Abstract

A vast spectrum of topical anti-acne agents has emerged in response to new insights that have been gained through the understanding of disease pathophysiology and the need for clinicians to adopt an individualized therapeutic approach. Because topical agents are most commonly used for acne management, this article reviews some novel vehicle delivery advances that are poised to further enhance the efficacy of topical acne formulations, and/or offer the possibility of simplified dosing regimens that may improve treatment outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18648713

Source DB:  PubMed          Journal:  Skin Therapy Lett        ISSN: 1201-5989


  5 in total

1.  The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes.

Authors:  Darren Yang; Dissaya Pornpattananangkul; Teruaki Nakatsuji; Michael Chan; Dennis Carson; Chun-Ming Huang; Liangfang Zhang
Journal:  Biomaterials       Date:  2009-08-08       Impact factor: 12.479

2.  In vivo treatment of Propionibacterium acnes infection with liposomal lauric acids.

Authors:  Dissaya Pornpattananangkul; Victoria Fu; Soracha Thamphiwatana; Li Zhang; Michael Chen; James Vecchio; Weiwei Gao; Chun-Ming Huang; Liangfang Zhang
Journal:  Adv Healthc Mater       Date:  2013-03-12       Impact factor: 9.933

Review 3.  Crucial functionalizations of carbon nanotubes for improved drug delivery: a valuable option?

Authors:  Giorgia Pastorin
Journal:  Pharm Res       Date:  2009-01-14       Impact factor: 4.200

Review 4.  Carrier-based drug delivery system for treatment of acne.

Authors:  Amber Vyas; Avinesh Kumar Sonker; Bina Gidwani
Journal:  ScientificWorldJournal       Date:  2014-02-09

Review 5.  Nanotechnology in dermatology.

Authors:  João Roberto Antonio; Carlos Roberto Antônio; Izabela Lídia Soares Cardeal; Julia Maria Avelino Ballavenuto; João Rodrigo Oliveira
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.